Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Rangering i aksjer #6138
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Aksjekurs
$154.04
Markedsverdi
$2.21B
Endring (1 dag)
-0.19%
Endring (1 år)
172.88%
Land
US
Handel Palvella Therapeutics, Inc. (PVLA)

Kategori

Aksjeprishistorikk for Palvella Therapeutics, Inc. (PVLA)
Høyeste sluttskurs: $151.69 den 2026-08-01

Laveste sluttskurs: $13.11 den 2024-12-01
Aksjeprishistorikk for Palvella Therapeutics, Inc. fra 2024 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 7.48%
2025 649.84%
2024 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$547.65 40.75%
US
$1.06K 49.04%
NL
$122.63 -12.65%
AU
$143.63 472.23%
US
$765.25 7.19%
CH